2 studies found for:    20018364 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Clinical Trial With Influenza A/H1N1 Vaccines
Condition: Influenza
Interventions: Biological: split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose;   Biological: split-virion, adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg per dose;   Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 5 μg per dose;   Biological: whole-virion, adjuvanted H1N1 vaccine of 10 μg per dose;   Biological: placebo control
2 Completed Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 7.5 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 15 μg;   Biological: Experimental: split-virion, adjuvanted H1N1 vaccine of 30 μg;   Biological: Experimental: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Biological: Placebo Comparator: Placebo control

Indicates status has not been verified in more than two years